ÂÜÀòÂÒÂ×

Dr. Rajani Kanth Vangala is a distinguished figure in the field of biotechnology and healthcare innovation, currently serving as the Co-Founder and CEO of Neuome Technologies Private Limited since April 2020. In addition to this role, Dr. Vangala is the Founder Director of the Institute for Applied Research and Innovation and the Scientific Editor for the Future Medicine Journal, both active since 2018. Prior experience includes leadership positions such as Director of the Thrombosis Research Institute and Head of Translational Research at the Thrombosis Research Institute Bangalore, where a focus on translating research into clinical practice was paramount. With extensive academic credentials, including a Ph.D. in Biotechnology from Ludwig-Maximilians-Universität München and multiple roles in research and management at institutions such as Imperial College London and InnovoBiologicals Pvt. Ltd, Dr. Vangala’s work emphasizes the integration of science and innovative technologies to enhance healthcare delivery.